GENSCRIPT BIO (01548): CARVYKTI generated approximately 524 million US dollars in trade sales revenue for the quarter ending September 30, 2025.
Kingray Biotechnology (01548) announced that, according to the agreement with Janssen Biotech, I...
GENSCRIPT BIO(01548) announced that, according to the collaboration and license agreement signed with Janssen Biotech, Inc. on December 21, 2017, CARVYKTI generated net sales of approximately $524 million in the quarter ending on September 30, 2025.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
